| Product NDC: | 50224-002 |
| Proprietary Name: | REFISSA |
| Non Proprietary Name: | TRETINOIN |
| Active Ingredient(s): | .5 mg/g & nbsp; TRETINOIN |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50224-002 |
| Labeler Name: | Suneva Medical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076498 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090617 |
| Package NDC: | 50224-002-05 |
| Package Description: | 40 g in 1 TUBE (50224-002-05) |
| NDC Code | 50224-002-05 |
| Proprietary Name | REFISSA |
| Package Description | 40 g in 1 TUBE (50224-002-05) |
| Product NDC | 50224-002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TRETINOIN |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20090617 |
| Marketing Category Name | ANDA |
| Labeler Name | Suneva Medical, Inc. |
| Substance Name | TRETINOIN |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |